As we continued our studies on cancer development and progression, we encountered therapy-induced senescence (TIS), a cellular fate induced by radiation and chemotherapy in both normal and tumor tissues. TIS is characterized by an irreversible exit from the cell cycle and the secretion of the Senescence-Associated Secretory Phenotype (SASP). The accumulation of senescent cells leads to tissue dysfunction and organ failure, contributing significantly to the side effects observed in cancer patients post-treatment. Additionally, these cells accumulate with age, contributing to frailty and decreased longevity.
Our data indicate that senescent cells rewire their ER-mitochondria communication, making them sensitive to InsP3R inhibition. Our current efforts focus on understanding the dynamics of ER-mitochondrial communication in the initiation and establishment of cellular senescence, with the ultimate goal of selectively targeting these cells or preventing their appearance. We are also investigating the role of other organelles, such as lysosomes, in this inter-organellar communication.